The nasal spray FluMist is made by AstraZeneca. Several other countries, like Canada and the United Kingdom, have already endorsed the use of the nasal spray over the shot for the flu vaccine.
The nasal spray uses trivalent live attenuated vaccine as opposed to inactivated influenza vaccine, according to the report. Four studies have shown fewer flu cases among children who receive the LAIV rather than the inactivated flu vaccine.
More Articles on Infection Prevention:
Toilets Remain Major Source of Viral Contamination in Healthcare Settings
Sepsis Conference Planned in Washington DC
Study: Front-Line Engagement, Education Can Reduce CLASBI Rates Outside ICU
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.